openPR Logo
Press release

Fragment-based Drug Discovery Market Covering Service Component, End-user, Trends, Analysis and Forecast to 2023

04-14-2017 03:50 PM CET | Health & Medicine

Press release from: Fragment-based Drug Discovery

ALBANY, NY, April 14, 2017 : The increasing search for new drugs to treat complicated medical problems has led to a surge in the global fragment-based drug discovery market. Furthermore, the growth of the global fragment-based drug discovery market has also led to dominance of biopharmaceutical companies, as the market requires a system for identification of lead compounds in the process of drug discovery.

The report published by Transparency Market Research on the global fragment-based drug discovery market gives a comprehensive overview of the important dynamics and trends. The report assesses the threat from new entrants, threat of substitute products or services, bargaining power of customers, bargaining power of suppliers, and the intensity of competitive rivalry with the help of a Porter’s five forces analysis. Furthermore, it also evaluates the strengths, weaknesses, opportunities, and threats of the market with the help of a SWOT analysis. The report gives a clear understanding of the competitive landscape and segmentation of the market and an overview of the global fragment-based drug discovery market to enable its readers to make well-informed business decisions.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=444862

Overview of Global Fragment-Based Drug Discovery Market

The drivers for the global fragment-based drug discovery market are its time-saving attributes and quick access to biophysical fragment screening techniques. Fragment-based drug discovery has become a method of designing unique molecules. This technique uses smaller ‘fragments or ligands’, which have lower molecular weights. The main restraint on the global fragment-based drug discovery market is the weak potency of a few compounds that are derived from fragment screening. The other conspicuous restraint on this market is the need for special ‘fragment libraries’ for conducting research.

The global fragment-based drug discovery market has been segmented into fragment screening and fragment optimization. The fragment screening segment is further sub-segmented into biophysical techniques and non-biophysical techniques. Biophysical techniques include isothermal titration calorimetry (ITC), nuclear magnetic resonance (NMR) spectroscopy, fluorescence polarization (FP), differential scanning fluorimetry (DSF), surface plasmon resonance, X-ray crystallography, assay (thermal shift), biolayer interferometry, capillary electrophoresis, mass spectrometry, and others (biochemical assays). The end-use applications encouraging the growth of this market are CROs, biopharmaceutical companies, and academic and research institutions. Geographically, the global fragment-based drug discovery market is divided into regions such as North America, Asia Pacific, Europe, Latin America, and Rest of the World.

North America dominated the global fragment-based drug discovery market due to growing awareness about this sector and the high level of its adoption by pharmaceutical companies. However, in the coming years, the Asia Pacific fragment-based drug discovery market will witness phenomenal growth due to the growing number of research and development activities.

Companies Mentioned in the Global Fragment-Based Drug Discovery Market Report

The important players in the global fragment-based drug discovery market are Astex Pharmaceuticals, Beactica AB, Structure Based Design, Inc., Alveus Pharmaceuticals Pvt. Ltd., Emerald BioStructures, Inc., Evotec AG, Crown Bioscience, Inc., Kinetic Discovery Limited, Sprint Bioscience, Proteros Fragments GmbH, Charles River Laboratories International, Inc., and Sygnature Discovery.

The global fragment-based drug discovery market has been segmented as follows:

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=444862

Fragment-Based Drug Discovery Market, by Services Component

Fragment Screening
Biophysical Techniques
Nuclear Magnetic Resonance (NMR) Spectroscopy
Differential scanning Fluorimetry (DSF) Assay (Thermal Shift)
Fluorescence Polarization (FP)
Isothermal Titration Calorimetry (ITC)
X-ray Crystallography
Surface Plasmon Resonance
Biolayer Interferometry
Mass Spectrometry
Capillary Electrophoresis
Others (Biochemical Assays)
Non-biophysical Techniques
Fragment Optimization

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
90 State Street,
Albany, NY 12207,
United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fragment-based Drug Discovery Market Covering Service Component, End-user, Trends, Analysis and Forecast to 2023 here

News-ID: 502883 • Views:

More Releases for Fragment

Gene Fragment Market Size, Share and Growth Report, 2034
" The global gene fragment market is projected to reach approximately $8.5 billion in 2024, driven by advances in molecular biology, synthetic biology, and personalized medicine. The forecast period from 2025 to 2034 anticipates robust growth, with market values expected to surge to around $18 billion by 2034. This translates to a Compound Annual Growth Rate (CAGR) of approximately 9.5%." Exactitude Consultancy., Ltd. released a research report titled "Gene Fragment Market".
DNA Fragment Synthesis Market to Witness Growth by 2024-2030
DNA fragment synthesis has emerged as a critical technology in the field of molecular biology and biotechnology, enabling the custom design and assembly of DNA sequences. This market is driven by the increasing demand for synthetic DNA in various applications, including gene editing, synthetic biology, and molecular diagnostics. The technology facilitates the creation of bespoke DNA fragments, offering researchers and biotech companies unprecedented control over genetic material. As the life
Global Fragment-Based Drug Discovery Market Outlook 2031
𝗚𝗹𝗼𝗯𝗮𝗹 𝗙𝗿𝗮𝗴𝗺𝗲𝗻𝘁-𝗕𝗮𝘀𝗲𝗱 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗢𝘂𝘁𝗹𝗼𝗼𝗸 𝟮𝟬𝟯𝟭 The global fragment-based drug discovery (FBDD) market is poised for remarkable growth, with a projected compound annual growth rate (CAGR) of 11.5% from 2023 to 2031. This innovative approach to early-stage drug development has gained substantial attention due to its ability to revolutionize the way we discover and develop new therapeutic agents. In 2022, the FBDD market was valued at US$ 795.4 million, and
Fragment-based Drug Discovery Market - Harnessing Fragment Power: Fueling Innova …
Newark, New Castle, USA - new report, titled Fragment-based Drug Discovery Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Fragment-based Drug Discovery market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Fragment-based Drug Discovery market. The report offers an overview of
Fragment-based Drug Discovery Market Key Trends & Industry Forecast 2015 - 2023
38.4% of the global fragment-based drug discovery market was collectively held by its top three players in 2014. Astex Pharmaceuticals, Charles River Laboratories International, Inc., and Sygnature Discovery were the key contributors to the market revenue at the time and are expected to retain their lead in the near future. A new research report released by Transparency Market Research states that with 52.3% of the global fragment-based drug discovery market
Fragment-based Drug Discovery Market USD 650 Million by 2020
The global fragment-based drug discovery market is estimated to reach USD 650 Million in 2020, growing at a CAGR of 10.6% from 2016 to 2020, according to a market research report Fragment-based Drug Discovery Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Fragment-based Drug Discovery Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/fragment-based-drug-discovery-market/ The global fragment-based drug discovery market segmentation is based on service types or components (comparative analysis of FBDD and HTS, fragment